|
First look: Princeton researchers peek into deepest recesses of human brain
February 29, 2008A team of scientists from Princeton University has devised a new experimental technique that produces some of the best functional images ever taken of the human brainstem, the most primitive area of the brain.
The scientists believe they may be opening the door to inquiries into a region that acts as the staging area for the brain chemicals whose overabundance or absence in other parts of the brain are at the root of many neuropsychiatric disorders, like addiction, schizophrenia and Parkinson's disease.
Reporting in the Feb. 28 edition of Science, the scientists describe using functional magnetic resonance imaging to study brainstem activity in dehydrated humans. The scanning technique allows researchers to watch the brain in action.
The subjects were participating in classical conditioning experiments in which they were presented with a visual clue, then, at varying intervals, given a drink. The researchers were able to track changes in blood flow in areas of the brainstem associated with enhanced activity of the brain chemical dopamine -- as the person experienced either pleasure or disappointment at receiving or not receiving the reward.
"For a long time, scientists have tried looking at this area of the brain and have been unsuccessful -- it's just too small," said Kimberlee D'Ardenne, the lead author on the paper. Until now, scientists wanting to use brain scans to study brain chemicals like dopamine were relegated to watching its effects in other more accessible parts of the brain, like the prefrontal cortex and ventral striatum. However, this was downstream of its source, and therefore possibly much less accurate, D'Ardenne said.
"We wanted to try because the brainstem is so important to activities in the rest of the brain," said D'Ardenne, a doctoral student in the Department of Chemistry. "We believe it could be a key to understanding all kinds of important behavior."
For the research, D'Ardenne collaborated with Jonathan Cohen, co-director of the Princeton Neuroscience Institute, and Samuel McClure and Leigh Nystrom, other institute scientists. They conducted the studies on the University's own brain scanner located on campus in Green Hall.
Cohen noted that these findings provide a critical link between studies in non-human animals that have looked directly at the activity of dopamine cells in the brainstem and studies in humans of behaviors thought to be related to dopamine. "It could also open up entirely new avenues of study," he said.
The team was able to develop high-resolution images that tracked the activity of tiny clusters of dopamine neurons. They weeded out distortions caused by many pulsing blood vessels in the brainstem. They also employed computerized rules of thumb known as algorithms and imaging techniques to reduce the effects of head movement and combine images from different subjects.
The MRI device produces three-dimensional images that show what portions of the brain engage during actions and thought processes. This allows the investigators to correlate physical processes with mental activities with unprecedented precision.
The brain stem, a tiny, root-shaped structure, is the lower part of the brain and sits atop the spinal cord. The area controls brain functions necessary for survival, such as breathing, digestion, heart rate, blood pressure and arousal. The brain structure also serves as the home base for the brain chemicals, also known as neuromodulators, such as dopamine, serotonin and norepinephrine. The chemicals spring forth into other brain regions from there, zipping along routes called axons.
The team's experiments confirmed results already seen in animal studies. Blood flow increased in dopamine centers of the brainstem when test subjects were happily surprised with a reward. However, there was no activity when participants received less than what they expected, a finding that is different from the results of previous studies looking farther downstream.
"We are just at the beginning of understanding these crucial pathways," D'Ardenne said. "But it gives us a hint about what is possible to know."
The tiny clumps of cells containing neuromodulator chemicals in the brainstem, called nuclei, have long been known to play a critical role in the regulation of brain function, and disturbances of these systems have been implicated in most psychiatric disorders, from addiction to schizophrenia, D'Ardenne said.
The Princeton group wants to understand how the brain's physical structures give rise to the functions of the mind, a field known as cognitive neuroscience.
For years, neuroscientists focused on the brain while psychologists dealt with the mind. The new field combines both and is being powered by scientific advances in brain imaging and gene manipulation that allows researchers to record and measure the activity of brain cells as humans or animals perform mental tasks.
Princeton University
The subjects were participating in classical conditioning experiments in which they were presented with a visual clue, then, at varying intervals, given a drink. The researchers were able to track changes in blood flow in areas of the brainstem associated with enhanced activity of the brain chemical dopamine -- as the person experienced either pleasure or disappointment at receiving or not receiving the reward.
"For a long time, scientists have tried looking at this area of the brain and have been unsuccessful -- it's just too small," said Kimberlee D'Ardenne, the lead author on the paper. Until now, scientists wanting to use brain scans to study brain chemicals like dopamine were relegated to watching its effects in other more accessible parts of the brain, like the prefrontal cortex and ventral striatum. However, this was downstream of its source, and therefore possibly much less accurate, D'Ardenne said.
"We wanted to try because the brainstem is so important to activities in the rest of the brain," said D'Ardenne, a doctoral student in the Department of Chemistry. "We believe it could be a key to understanding all kinds of important behavior."
For the research, D'Ardenne collaborated with Jonathan Cohen, co-director of the Princeton Neuroscience Institute, and Samuel McClure and Leigh Nystrom, other institute scientists. They conducted the studies on the University's own brain scanner located on campus in Green Hall.
Cohen noted that these findings provide a critical link between studies in non-human animals that have looked directly at the activity of dopamine cells in the brainstem and studies in humans of behaviors thought to be related to dopamine. "It could also open up entirely new avenues of study," he said.
The team was able to develop high-resolution images that tracked the activity of tiny clusters of dopamine neurons. They weeded out distortions caused by many pulsing blood vessels in the brainstem. They also employed computerized rules of thumb known as algorithms and imaging techniques to reduce the effects of head movement and combine images from different subjects.
The MRI device produces three-dimensional images that show what portions of the brain engage during actions and thought processes. This allows the investigators to correlate physical processes with mental activities with unprecedented precision.
The brain stem, a tiny, root-shaped structure, is the lower part of the brain and sits atop the spinal cord. The area controls brain functions necessary for survival, such as breathing, digestion, heart rate, blood pressure and arousal. The brain structure also serves as the home base for the brain chemicals, also known as neuromodulators, such as dopamine, serotonin and norepinephrine. The chemicals spring forth into other brain regions from there, zipping along routes called axons.
The team's experiments confirmed results already seen in animal studies. Blood flow increased in dopamine centers of the brainstem when test subjects were happily surprised with a reward. However, there was no activity when participants received less than what they expected, a finding that is different from the results of previous studies looking farther downstream.
"We are just at the beginning of understanding these crucial pathways," D'Ardenne said. "But it gives us a hint about what is possible to know."
The tiny clumps of cells containing neuromodulator chemicals in the brainstem, called nuclei, have long been known to play a critical role in the regulation of brain function, and disturbances of these systems have been implicated in most psychiatric disorders, from addiction to schizophrenia, D'Ardenne said.
The Princeton group wants to understand how the brain's physical structures give rise to the functions of the mind, a field known as cognitive neuroscience.
For years, neuroscientists focused on the brain while psychologists dealt with the mind. The new field combines both and is being powered by scientific advances in brain imaging and gene manipulation that allows researchers to record and measure the activity of brain cells as humans or animals perform mental tasks.
Princeton University
Dopamine News and Current Dopamine Events RSSDid the gene for ADHD help our nomadic ancestors?
An ADHD-associated version of the human gene DRD4 is linked to better health among nomadic tribesmen, but may cause malnourishment in their settled cousins, according to new research by a team directed by an anthropologist at the University of Wisconsin-Milwaukee (UWM).
NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression
New findings from research supported by NARSAD, the world's leading charity dedicated to mental health research, and conducted by Harvard-affiliated scientists are providing important clues into how genes work to impair various aspects of attention, memory and perception -- the behaviors associated with many psychiatric illnesses, such as schizophrenia, bipolar disorder and depression.
Are Anxiety Disorders All in the Mind?
Using single-photon emission computed tomography (SPECT), researchers in The Netherlands were able to detect biochemical differences in the brains of individuals with generalized social anxiety disorder (also known as social phobia), providing evidence of a long-suspected biological cause for the dysfunction.
Lack of motivation in schizophrenia linked to brain chemical imbalance
A study of patients with psychotic illnesses such as schizophrenia suggests an alternative explanation for why many sufferers lack motivation. The research is described today BioMed Central's journal BMC Psychiatry.
Cell-Based Therapy Shows Promise in Patients with Parkinson's Disease
A novel cell therapy using retinal pigment epithelial (RPE) cells attached to tiny gelatin bead microcarriers implanted in the brain can improve the symptoms of patients with moderate to advanced Parkinson's disease (PD).
Rat study suggests why teens get hooked on cocaine more easily than adults
New drug research suggests that teens may get addicted and relapse more easily than adults because developing brains are more powerfully motivated by drug-related cues.
U of M researchers identify process that may help treat Parkinson's, spinal cord injuries
A new discovery by University of Minnesota researchers may lead to a better understanding of how the spinal cord controls how people walk. These insights could help lead to treatments for central nervous system maladies such as Parkinson's disease and spinal cord injuries.
Gene therapy reduces cocaine use in rats
Researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that increasing the brain level of receptors for dopamine, a pleasure-related chemical, can reduce use of cocaine by 75 percent in rats trained to self-administer it.
Blood urate levels associated with the progression of Parkinson's disease
Higher blood levels of the compound urate, a salt derived from uric acid that is associated with gout, may be associated with a slower progression of Parkinson's disease.
Repeated methamphetamine use causes long-term adaptations in brains of mice, researchers find
Repeatedly stimulating the mouse brain with methamphetamine depresses important areas of the brain, and those changes can only be undone by re-introducing the drug, according to research at the University of Washington and other institutions.
More Dopamine News Articles
| © 2008 BrightSurf.com |